How to Source Discontinued or Hard to Find Medical Devices Responsibly

A risk based approach to legacy references, remaining stock, product condition, support status and controlled replacement planning. The purpose is to help teams make a clearer, better documented decision without turning a commercial checklist into a clinical recommendation.

Quick answer

A hard to find reference can create pressure to accept unclear stock, very short expiry, unsupported equipment or unauthorised substitutions. A stronger approach produces a documented decision that distinguishes genuine remaining stock from an appropriate replacement strategy.

This cluster article supports the broader guide on Multi Brand Medical Device Sourcing: Benefits, Risks and Controls. The main search topic for this guide is discontinued medical device sourcing. Related language includes hard to find medical devices, obsolete medical equipment parts, medical device shortage sourcing, but the article uses those terms only where they help the reader rather than repeating them mechanically.

Why this matters

Sourcing adds value when it turns a difficult request into a verified, deliverable option. It does not remove the need for exact references, transparent assumptions, appropriate documentation and authorised approval for any change.

For hospital procurement, biomedical teams, distributors and clinical operations, the practical risk is not limited to price. A wrong reference, incomplete pack, uncertain shelf life, late shipment or unsupported alternative can create rework, unused inventory and avoidable delays. A useful buying process therefore connects the technical request, commercial offer and receiving standard.

The best time to resolve ambiguity is before the purchase order. Once goods are dispatched, every unclear field becomes harder and more expensive to correct. The controls below are designed to move important questions to the beginning of the process.

Key checks

These checks should be adapted to product risk and organisational policy. A routine low risk item and a sterile implantable or procedure critical device should not automatically receive the same depth of review.

A practical workflow

1. Step 1: Confirm the legacy requirement and why it remains necessary. Record the owner, evidence and completion date so the action can be checked later.
2. Step 2: Verify discontinuation or supply status through reliable channels. Record the owner, evidence and completion date so the action can be checked later.
3. Step 3: Search using the exact reference and revision. Record the owner, evidence and completion date so the action can be checked later.
4. Step 4: Apply enhanced source, condition and traceability checks. Record the owner, evidence and completion date so the action can be checked later.
5. Step 5: Limit quantity to justified demand and usable life. Record the owner, evidence and completion date so the action can be checked later.
6. Step 6: Develop a clinically and technically approved transition plan. Record the owner, evidence and completion date so the action can be checked later.

A workflow is only useful when exceptions are visible. If a field is unknown, mark it as unknown and assign an owner. Do not fill the gap with an assumption merely to complete the form. The decision record should show what was confirmed, what remained conditional and which stakeholder accepted the residual risk.

Documentation and verification

A supplier should be able to explain what is available, from where, in what condition, with which documents and by what date. When one of those elements is uncertain, the quotation should state the limitation instead of presenting an estimate as a confirmed fact.

The final record should preserve the original requirement and every approved deviation. This is particularly important for legacy, discontinued, independently sourced or substituted devices where future staff may not know why the decision was made.

For every important document, record the document title, issuing organisation, product or company scope, version or validity date, source and date reviewed. This simple index helps prevent a valid document from being attached to the wrong product or reused after it becomes outdated.

Minimum decision record

• The original request and clinician or technical approval where required
• The exact quoted product identity, pack and quantity
• Supplier assumptions, deviations and proposed alternatives
• Quality, regulatory and traceability evidence proportionate to risk
• Price basis, landed cost assumptions, lead time and shelf life
• Approval names, dates and any conditions
• Receiving checks and final disposition of discrepancies

Questions to ask before approval

• Can the supplier demonstrate the discontinuation evidence described in the RFQ, and can the answer be connected to the exact quoted product?
• Can the supplier demonstrate the exact legacy identity described in the RFQ, and can the answer be connected to the exact quoted product?
• Can the supplier demonstrate the condition and expiry described in the RFQ, and can the answer be connected to the exact quoted product?
• Can the supplier demonstrate the support and recall status described in the RFQ, and can the answer be connected to the exact quoted product?
• Can the supplier demonstrate the replacement pathway described in the RFQ, and can the answer be connected to the exact quoted product?

Ask suppliers to answer against each RFQ line rather than in a general email. A line level response makes it easier to compare offers, detect partial matches and transfer the approved information into the purchase order.

Common mistakes

• Buying excess legacy stock without expiry or demand analysis. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.
• Accepting refurbished or opened items as new. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.
• Assuming a later model is automatically compatible. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.
• Waiting until zero stock to begin replacement review. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.

Most procurement errors are not caused by one dramatic failure. They develop through several small gaps, such as an abbreviated name, an unrecorded assumption and a receiving check that compares quantity but not reference. Closing those gaps consistently is more effective than adding a large document request after a problem occurs.

Practical example

The lesson is not that every enquiry must become slow. A structured template is usually faster because it reduces repeated emails and makes approval requirements visible from the start.

Final checklist

• ✓ Discontinuation evidence has been reviewed: Confirm whether the product is discontinued, regionally unavailable or only temporarily out of stock.
• ✓ Exact legacy identity has been reviewed: Record model, reference, software or hardware revision and compatible system.
• ✓ Condition and expiry has been reviewed: Verify unused status, packaging, storage history and remaining life.
• ✓ Support and recall status has been reviewed: Check service, parts, safety notices and manufacturer support implications.
• ✓ Replacement pathway has been reviewed: Start a controlled alternative review before remaining stock is exhausted.

Before closing the file, confirm that the purchase order reflects the approved quotation rather than an earlier draft. At receiving, compare the physical label and condition with the same approved record. This completes the link between request, order and delivered product.

Frequently asked questions

Related AJA guides

• Multi Brand Medical Device Sourcing: Benefits, Risks and ControlsA balanced framework for using multi brand sourcing while protecting product identity, documentation, supply continuity and clinical governance.
• Medical Device Reference Numbers: Preventing Wrong Item OrdersA practical guide to catalogue numbers, model numbers, SKUs, UDI data and internal codes in purchasing workflows.
• Product Substitution in Medical Procurement: A Controlled ApproachA governance framework for proposed alternatives when the requested device is unavailable, delayed or discontinued.
• Instructions for Use and Product Labelling: A Procurement Review GuideA procurement review of IFU availability, label consistency, language, storage, identifiers and supplied configuration.

Browse the medical device product catalogue, review the brand sourcing profiles or read about AJA International’s quality and compliance approach.

Official resources and further reading

• WHO medical devices resources
• AccessGUDID public device database
• UAE Ministry of Health and Prevention services

Editorial review: Prepared for publication in 2026. Regulatory, registration and product information can change, so readers should confirm current requirements and manufacturer documentation before acting.